Issue 43, 2016

Developing a self-healing supramolecular nucleoside hydrogel

Abstract

Low molecular weight gelator hydrogels provide a viable alternative to traditional polymer based drug delivery platforms, owing to their tunable stability and in most cases inherent biocompatibility. Here we report the first self-healing nucleoside hydrogel using N4-octanoyl-2′-deoxycytidine (0.5% w/v) for drug delivery. The hydrogel's cross-linked nanofibrillar structure, was characterised using oscillatory rheology and confirmed using SEM and TEM imaging. The potential of this gel for drug delivery was explored in vitro using fluorescently labelled tracers. Cell viability assays were conducted using pancreatic cell lines which tolerated the gels well; whilst no adverse effects on the viability or proliferation of cells were observed for fibroblast cell lines.

Graphical abstract: Developing a self-healing supramolecular nucleoside hydrogel

Supplementary files

Article information

Article type
Paper
Submitted
02 Aug 2016
Accepted
19 Sep 2016
First published
21 Sep 2016

Soft Matter, 2016,12, 8950-8957

Developing a self-healing supramolecular nucleoside hydrogel

K. J. Skilling, B. Kellam, M. Ashford, T. D. Bradshaw and M. Marlow, Soft Matter, 2016, 12, 8950 DOI: 10.1039/C6SM01779G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements